Journal of Critical Care
Volume 23, Issue 1 , Pages 50-57 , March 2008

The value of pretest probability and modified clinical pulmonary infection score to diagnose ventilator-associated pneumonia

  • François Lauzier, MD, MSc

      Affiliations

    • Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    • Department of Medicine, Université Laval, Québec City, Québec, Canada
  • ,
  • Annie Ruest, MD

      Affiliations

    • Department of Medicine, Université Laval, Québec City, Québec, Canada
    • Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
  • ,
  • Deborah Cook, MD, MSc

      Affiliations

    • Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    • Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
  • ,
  • Peter Dodek, MD, MSc

      Affiliations

    • Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada
  • ,
  • Martin Albert, MD

      Affiliations

    • Department of Medicine, Université de Montréal, Montréal, Québec, Canada
  • ,
  • Andrew F. Shorr, MD, MSc

      Affiliations

    • Pulmonary and Critical Care Medicine, Washington Hospital Center, Washington, DC, USA
  • ,
  • Andrew Day, MSc

      Affiliations

    • Clinical Evaluation Research Unit, Kingston General Hospital, Kingston, Ontario, Canada
  • ,
  • Xuran Jiang, MSc

      Affiliations

    • Clinical Evaluation Research Unit, Kingston General Hospital, Kingston, Ontario, Canada
  • ,
  • Daren Heyland, MD, MSc

      Affiliations

    • Clinical Evaluation Research Unit, Kingston General Hospital, Kingston, Ontario, Canada
    • Department of Medicine, Queen's University, Kingston, Ontario, Canada
    • Corresponding Author InformationCorresponding author. Tel.: +613 549 6666x3339; fax: +613 548 1351.
  • ,
  • for the Canadian Critical Care Trials Group

References 

  1. Bowen JL. Educational strategies to promote clinical diagnostic reasoning. N Engl J Med. 2006;355:2217–2225
  2. Elstein AS, Schwartz A. Clinical problem solving and diagnostic decision making: selective review of the cognitive literature. BMJ. 2002;324:729–732
  3. Horan TC, Gaynes RP. Surveillance of nosocomial infections. In:  Mayhall CG editors. Hospital Epidemiology and Infection Control. 3rd ed.. Philadelphia, Lippincott: Williams & Wilkins; 2004;p. 1659–1702
  4. Fagon JY, Chastre J, Hance AJ, et al. Evaluation of clinical judgment in the identification and treatment of nosocomial pneumonia in ventilated patients. Chest. 1993;103:547–553
  5. Andrews CP, Coalson JJ, Smith JD, et al. Diagnosis of nosocomial bacterial pneumonia in acute, diffuse lung injury. Chest. 1981;80:254–258
  6. Bell RC, Coalson JJ, Smith JD, et al. Multiple organ system failure and infection in adult respiratory distress syndrome. Ann Intern Med. 1983;99:293–298
  7. Fagon JY, Chastre J, Hance AJ, et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med. 1993;94:281–288
  8. Papazian L, Thomas P, Garbe L, et al. Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia. Am J Respir Crit Care Med. 1995;152:1982–1991
  9. Sutherland KR, Steinberg KP, Maunder RJ, et al. Pulmonary infection during the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1995;152:550–556
  10. Timsit JF, Misset B, Goldstein FW, et al. Reappraisal of distal diagnostic testing in the diagnosis of ICU-acquired pneumonia. Chest. 1995;108:1632–1639
  11. Klompas M. Does this patient have ventilator-associated pneumonia?. JAMA. 2007;297:1583–1593
  12. Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med. 1998;157:531–539
  13. Wey SB, Mori M, Pfaller MA, et al. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med. 1989;149:2349–2353
  14. Johnson S, Gerding DN. Clostridium difficile–associated diarrhea. Clin Infect Dis. 1998;26:1027–1034[quiz 1035-6]
  15. Kollef MH, Sherman G, Ward S, et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115:462–474
  16. Pugin J, Auckenthaler R, Mili N, et al. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic “blind” bronchoalveolar lavage fluid. Am Rev Respir Dis. 1991;143:1121–1129
  17. Fartoukh M, Maitre B, Honore S, et al. Diagnosing pneumonia during mechanical ventilation: the clinical pulmonary infection score revisited. Am J Respir Crit Care Med. 2003;168:173–179
  18. Luyt CE, Chastre J, Fagon JY. Value of the clinical pulmonary infection score for the identification and management of ventilator-associated pneumonia. Intensive Care Med. 2004;30:844–852
  19. Schurink CA, Van Nieuwenhoven CA, Jacobs JA, et al. Clinical pulmonary infection score for ventilator-associated pneumonia: accuracy and inter-observer variability. Intensive Care Med. 2004;30:217–224
  20. Croce MA, Swanson JM, Magnotti LJ, et al. The futility of the clinical pulmonary infection score in trauma patients. J Trauma. 2006;60:523–527discussion 527-8
  21. Heyland D, Cook D, Dodek P, et al. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med. 2006;355:2619–2630
  22. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818–829
  23. Singh N, Rogers P, Atwood CW, et al. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med. 2000;162:505–511
  24. Armitage P. Test for linear trend in proportions and frequencies. Biometrics. 1955;11:375–386
  25. Fabregas N, Ewig S, Torres A, et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax. 1999;54:867–873
  26. Michaud S, Suzuki S, Harbarth S. Effect of design-related bias in studies of diagnostic tests for ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;166:1320–1325
  27. Gibot S, Cravoisy A, Levy B, et al. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med. 2004;350:451–458
  28. Duflo F, Debon R, Monneret G, et al. Alveolar and serum procalcitonin: diagnostic and prognostic value in ventilator-associated pneumonia. Anesthesiology. 2002;96:74–79

 This study was supported by grants from the Canadian Institutes of Health Research and Physicians' Services Incorporated of Ontario, and by unrestricted grants from AstraZeneca and Bayer. François Lauzier and Annie Ruest are supported by a postdoctoral fellowship award from Université Laval. Annie Ruest is supported by a postdoctoral fellowship award from the Fonds de Recherche en Santé du Québec. Deborah Cook holds a Research Chair of the Canadian Institutes of Health Research.

PII: S0883-9441(08)00021-X

doi: 10.1016/j.jcrc.2008.01.006

Journal of Critical Care
Volume 23, Issue 1 , Pages 50-57 , March 2008